Navigation Links
International Survey of T2* Cardiovascular Magnetic Resonance in Thalassemia
Date:6/15/2012

AMSTERDAM, June 15, 2012 /PRNewswire/ --

"There is a large potential opportunity for saving lives by early identification of cardiac iron loading in Thalassemia patients", declares Professor John-Paul Carpenter of the Royal Brompton CMR Unit in London at the 17th Congress of the European Hematology Association in Amsterdam.

Thalassemia major (TM) is a substantial health issue, with over 25,000 new transfusion-dependent children identified each year around the world. In most TM patients who receive regular transfusions, the accumulation of cardiac iron is the cause of heart failure and early death. T2* cardiovascular magnetic resonance (CMR) provides a calibrated and reproducible measurement of myocardial iron which has contributed to improved survival in TM patients. However, there is little data regarding myocardial iron loading and its relation to outcome across the world.

We report a survey of 3,411 patients in 34 centres which use T2* CMR. Even in this cohort of well-treated TM patients from across the world which had access to regular transfusion, chelation and T2* CMR, a large proportion (42.3%) had moderate or severe myocardial iron loading. There were substantial regional differences in the prevalence of cardiac iron overload which, despite differences in clinical care, may indicate varying predisposition to myocardial iron loading. T2* CMR identified those patients at increased risk with myocardial T2* values <10ms being strongly associated with the future development of cardiac failure and death. There is a large potential opportunity for saving lives by early identification of cardiac iron loading and T2* CMR needs to be more widely available.

About the EHA Annual Congress

After 16 congresses and constantly increasing number of delegates, the 17th Congress of EHA is taking place in Amsterdam. Hematology is a specialty that covers everything to do with blood: its origin in the bone marrow, diseases (in the production) of blood and their treatments. The latest data on research and developments within the wide spectrum of hematology are presented.


'/>"/>
SOURCE European Hematology Association
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
2. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
3. Goddard collaborates with international partners on MMS instrument
4. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
5. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
6. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
7. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
8. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
9. Alchem International Opens Sales and Marketing Office in the U.S.
10. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
11. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 21, 2017   Boston Biomedical , an industry ... target cancer stemness pathways, today presented data from two ... the 2017 American Society of Clinical Oncology (ASCO) Gastrointestinal ... In a Phase Ib/II study of ... inhibit cancer stemness pathways by targeting STAT3 – colorectal ...
(Date:1/20/2017)... , ... January 20, 2017 ... ... Less Exposure Surgery (LES®) Technologies, announced today the next evolution in spinal ... Screw System platform). In contrast to the competition, SpineFrontier is focused on ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the ... 2025" report to their offering. Report ... provides a detailed analysis on current and future market trends to identify ... market values as the base numbers Key market trends ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
Breaking Biology Technology:
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at ... global leader in connected health and biometric measurement devices and services, will ... On display in A&D Medical,s special CES Exhibit Suite ... the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... NEW YORK , December 22, 2016 ... global provider of secure solutions for the e-Government, Public Safety, HealthCare, ... a subsidiary of SuperCom, has been selected to implement and deploy ... county in Northern California , further expanding its ... ...
(Date:12/16/2016)... Dec. 16, 2016   IdentyTechSolutions America LLC ... products and solutions and a cutting-edge manufacturer of ... it is offering seamless, integrated solutions that comprise ... products. The solutions provide IdentyTech,s customers with combined ... facilities from crime and theft. "We ...
Breaking Biology News(10 mins):